Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to email@example.com,we will inform you when we have it in stock.
|Product name：Rapamycin (Sirolimus)
||Solubility：Soluble in DMSO
||Package：Packaging according to customer requirements
||Storage：Store at -20℃
Rapamycin inhibits endogenous mTOR activity in HEK293 cells with IC50 of ~0.1 nM, more potently than iRap and AP21967 with IC50 of ~5 nM and ~10 nM, respectively.  In Saccharomyces cerevisiae, Rapamycin treatment induces a severe G1/S cell cycle arrest and inhibition of translation initiation to levels below 20% of control.  Rapamycin significantly inhibits the cell viability of T98G and U87-MG in a dose-dependent manner with IC50 of 2 nM and 1 μM, respectively, while displaying little activity against U373-MG cells with IC50 of >25 μM despite the similar extent of the inhibition of mTOR signaling. Rapamycin (100 nM) induces G1 arrest and autophagy but not apoptosis in Rapamycin-sensitive U87-MG and T98G cells by inhibiting the function of mTOR. 
 Edwards SR, et al. J Biol Chem, 2007, 282(18), 13395-13401.
 Barbet NC, et al. Mol Biol Cell, 1996, 7(1), 25-42.
 Takeuchi H, et al. Cancer Res, 2005, 65(8), 3336-3346.